A detailed history of Clifford Swan Investment Counsel LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 8,421 shares of BDX stock, worth $1.92 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,421
Previous 8,771 3.99%
Holding current value
$1.92 Million
Previous $2.05 Million 0.93%
% of portfolio
0.07%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $77,514 - $84,843
-350 Reduced 3.99%
8,421 $2.03 Million
Q2 2024

Aug 06, 2024

SELL
$225.07 - $246.17 $59,868 - $65,481
-266 Reduced 2.94%
8,771 $2.05 Million
Q1 2024

Apr 16, 2024

SELL
$233.45 - $247.73 $54,393 - $57,721
-233 Reduced 2.51%
9,037 $2.24 Million
Q4 2023

Feb 06, 2024

SELL
$232.24 - $267.23 $103,579 - $119,184
-446 Reduced 4.59%
9,270 $2.26 Million
Q3 2023

Nov 09, 2023

SELL
$254.9 - $283.59 $57,097 - $63,524
-224 Reduced 2.25%
9,716 $2.51 Million
Q2 2023

Aug 03, 2023

SELL
$238.39 - $265.32 $28,130 - $31,307
-118 Reduced 1.17%
9,940 $2.62 Million
Q1 2023

May 05, 2023

SELL
$229.71 - $259.35 $41,577 - $46,942
-181 Reduced 1.77%
10,058 $2.49 Million
Q4 2022

Feb 02, 2023

SELL
$218.29 - $256.91 $104,560 - $123,059
-479 Reduced 4.47%
10,239 $2.6 Million
Q3 2022

Nov 04, 2022

SELL
$51.03 - $264.23 $8,164 - $42,276
-160 Reduced 1.47%
10,718 $2.39 Million
Q2 2022

Aug 04, 2022

SELL
$234.74 - $275.42 $19,718 - $23,135
-84 Reduced 0.77%
10,878 $2.68 Million
Q1 2022

May 03, 2022

SELL
$243.64 - $270.48 $96,725 - $107,380
-397 Reduced 3.5%
10,962 $2.92 Million
Q4 2021

Feb 11, 2022

SELL
$230.08 - $250.94 $1,610 - $1,756
-7 Reduced 0.06%
11,359 $2.79 Million
Q3 2021

Nov 02, 2021

SELL
$232.72 - $256.47 $199,208 - $219,538
-856 Reduced 7.0%
11,366 $2.73 Million
Q2 2021

Aug 05, 2021

SELL
$232.65 - $254.58 $138,892 - $151,984
-597 Reduced 4.66%
12,222 $3.11 Million
Q1 2021

May 07, 2021

BUY
$232.09 - $256.88 $211,201 - $233,760
910 Added 7.64%
12,819 $3.12 Million
Q4 2020

Feb 11, 2021

SELL
$221.92 - $245.94 $253,432 - $280,863
-1,142 Reduced 8.75%
11,909 $2.98 Million
Q3 2020

Oct 30, 2020

SELL
$215.77 - $276.76 $157,943 - $202,588
-732 Reduced 5.31%
13,051 $3.04 Million
Q2 2020

Aug 06, 2020

SELL
$219.9 - $263.41 $100,274 - $120,114
-456 Reduced 3.2%
13,783 $3.3 Million
Q1 2020

Apr 09, 2020

SELL
$195.69 - $279.01 $418,580 - $596,802
-2,139 Reduced 13.06%
14,239 $3.27 Million
Q4 2019

Jan 30, 2020

SELL
$236.45 - $266.82 $223,445 - $252,144
-945 Reduced 5.46%
16,378 $4.45 Million
Q3 2019

Nov 12, 2019

SELL
$230.58 - $256.08 $243,261 - $270,164
-1,055 Reduced 5.74%
17,323 $4.38 Million
Q2 2019

Aug 13, 2019

SELL
$217.4 - $246.08 $264,141 - $298,987
-1,215 Reduced 6.2%
18,378 $4.63 Million
Q1 2019

May 14, 2019

SELL
$206.05 - $248.17 $278,373 - $335,277
-1,351 Reduced 6.45%
19,593 $4.89 Million
Q4 2018

Feb 13, 2019

SELL
$204.73 - $257.93 $199,816 - $251,739
-976 Reduced 4.45%
20,944 $4.72 Million
Q3 2018

Nov 14, 2018

SELL
$233.07 - $256.0 $238,896 - $262,400
-1,025 Reduced 4.47%
21,920 $5.72 Million
Q2 2018

Aug 13, 2018

SELL
$208.1 - $233.85 $203,938 - $229,173
-980 Reduced 4.1%
22,945 $5.5 Million
Q1 2018

May 09, 2018

SELL
$205.46 - $240.27 $379,484 - $443,778
-1,847 Reduced 7.17%
23,925 $5.19 Million
Q4 2017

Feb 09, 2018

BUY
$189.0 - $222.64 $3.22 Million - $3.79 Million
17,035 Added 194.98%
25,772 $5.52 Million
Q3 2017

Nov 13, 2017

SELL
$186.89 - $198.9 $233,051 - $248,028
-1,247 Reduced 12.49%
8,737 $1.71 Million
Q2 2017

Aug 11, 2017

BUY
N/A
9,984
9,984 $1.95 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.